OptimizeRx Shares Are Trading Lower After RBC Capital Downgraded the Stock From Outperform to Sector Perform and Cut Its Price Target From $7 to $6.
Accolade Analyst Ratings
Instacart Grows Stronger: S&P MidCap 400 Inclusion, Ulta Partnership Boosts Stock
Lindsay Analyst Ratings
Phillips Edison Stock Is Up Wednesday After CEO Comments On $300M Deal Activity
HC Wainwright & Co. Maintains Buy on Compass Therapeutics, Maintains $10 Price Target
HC Wainwright & Co. Maintains Buy on Absci, Maintains $7 Price Target
Absci Analyst Ratings
Nvidia CEO Sends Quantum Stocks Lower: Poll Finds Over 50% Pick Rigetti Or Skip For 2025
Build-A-Bear CEO Sells 69K Shares
Netstreit Analyst Ratings
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Earnings Call Summary | AngioDynamics(ANGO.US) Q2 2025 Earnings Conference
Merck Rival Summit Draws New Buy From Truist on Deal Prospects
PulteGroup Upgraded to Buy at UBS; MTH Named Top Homebuilder Pick
Keefe, Bruyette & Woods Maintains Outperform on Radian Group, Lowers Price Target to $40
Radian Group Analyst Ratings
NMI Holdings Analyst Ratings
Essent Group Analyst Ratings
EVgo Expects to Triple Its Charging Network by 2029 With Help From DofE and General Motors